Medicamen Biotech Concludes 33rd AGM and Key Resolution Voting
Medicamen Biotech Ltd 路 Annual General Meeting 路 26 Sept 2026, 9:01 pm
Medicamen Biotech Concludes 33rd AGM and Key Resolution Voting Medicamen Biotech Limited held its 33rd Annual General Meeting on 26th Sep'26 via video conferencing. Key resolutions tabled for shareholder approval included adoption of audited standalone and consolidated FY26 financial statements, dividend declaration on equity shares, re-appointment of retiring directors, and ratification of cost auditors' remuneration. Crucially, ordinary resolutions were presented to approve material related-party transactions with holding firm Shivalik Rasayan Limited and subsidiary Medicamen Life Sciences Private Limited. Remote e-voting concluded on 25th Sep'26, with final scrutinizer results to be disclosed post-meeting.
Original exchange filing (PDF)
More announcements from Medicamen Biotech Ltd
- Medicamen Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Financial Results - Quarter and Half year ended on September 30, 2026 路 13 Nov 2026
- MEDICAMEN BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 13 Nov 2026
- MEDICAMEN BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 13 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 13 Nov 2026
- Medicamen Biotech Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve the unaudited financial .... 路 13 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shivalik Rasayan Ltd & Growel Remedies Ltd 路 26 Oct 2026
- Outcome of the meeting of Preferential Issue Commitee of the Board of Directors of Medicamen Biotech Limited to consider and approve the allotmentb of 5,00,000 Equity Shares pursuant to .... 路 23 Oct 2026
